Tailored for Indian hospitals and diagnostic centers, focusing on high accuracy and patient comfort.
The In Vitro Diagnostic (IVD) market in India is currently undergoing a seismic shift. As the world's most populous nation, India faces unique healthcare challenges, from managing chronic non-communicable diseases (NCDs) like diabetes and cardiovascular issues to controlling infectious diseases such as H. Pylori and Tuberculosis. As a premier IVD systems manufacturer and supplier in India, we recognize that the local industry is no longer just about importing technology—it is about high-precision localization and accessibility.
With the Indian government's "Ayushman Bharat" initiative, there is a massive push towards early screening and preventive diagnostics. This has catalyzed the demand for automated biochemistry analyzers, molecular diagnostic systems, and point-of-care (POC) devices across Tier-1 metro cities like Mumbai, Delhi, and Bangalore, as well as developing Tier-2 and Tier-3 healthcare clusters.
Ningbo Medvok Medical Co., Ltd. is a high-tech biotechnology company focused on the R&D and production of antigens, antibodies and downstream detection reagents for diagnosis and therapy. The product pipelines cover cardiovascular and cerebrovascular, inflammation, infectious diseases, tumors, hormones and other categories, from raw materials to finished products.
Innovation is in our DNA! Bioantibody keeps developing new technologies. Currently, our products have been delivered to more than 60 countries and cities worldwide. Using the ISO 13485 management system, the product quality is greatly trusted by customers. With the mission "Biotech For A Better Life", we are committed to innovation and providing our best solutions to our customers. We sincerely believe we could make our special contribution to human ecology and health.
Countries Served
13485 Certified
India's shortage of specialized pathologists in rural areas is being bridged by AI-integrated analyzers. Our systems provide automated flagging of anomalies, ensuring diagnostic consistency in remote Indian districts.
Post-pandemic, the Indian consumer shift toward home health monitoring is significant. Systems like the Accu Answer 4-in-1 are becoming household essentials for managing the nation's diabetes epidemic.
In high-pressure environments like city government hospitals (AIIMS, Safdarjung), POCT breath test systems allow for immediate screening of GI distress without invasive procedures.
With water scarcity in several Indian states, our RO Water Treatment Plants for laboratories ensure that high-throughput analyzers function with ultra-pure water, extending equipment life.
As an IVD solutions provider, we have worked and will keep working intensively to support research and foment knowledge and prevention of the diseases. For us, a well-informed society is a healthier society. We care about protecting the human health and hope all of society to have access to clean, affordable, and reliable biotechnologies. Furthermore, our economic development will be compatible with proper conduct in relation to ethics, society, the workplace, the environment and respect for human rights.
From biochemistry to molecular biology, discover our full spectrum of diagnostic hardware.
In order to materialize our commitment to the Indian market, we have developed a sustainability policy on environmental and social matters. We recognize that In Vitro Diagnostic Systems Manufacturers and Suppliers in India play a critical role in the country’s GDP and overall human index. Our systems are designed to be energy-efficient and minimize chemical waste, aligning with India's "Green Lab" initiatives.
The prevalence of Helicobacter pylori in the Indian population is notably high, often linked to chronic gastritis and peptic ulcers. Traditional gastroscopy is often perceived as invasive and expensive by many in rural India. Our C13 Breath Test Systems provide a non-radioactive, non-invasive alternative that is perfect for community-wide screening in states like West Bengal, Bihar, and Maharashtra, where GI issues are prevalent. By supplying these systems to local Indian distributors, we are effectively lowering the barrier to high-end medical technology.
As we look toward 2030, the integration of Internet of Medical Things (IoMT) will be the standard. Our current range of Biobase chemistry analyzers and immunoassay systems are built with data connectivity in mind, allowing Indian lab managers to monitor test results and reagent levels remotely. This digital synergy is vital for the upcoming "Smart Hospitals" in cities like Hyderabad and Pune.
We think of society as a group of individuals with equal rights and opportunities. By providing cost-effective, high-precision diagnostic systems across India, we are ensuring that whether a patient is in a high-end Delhi hospital or a community clinic in Kerala, they receive the same standard of diagnostic accuracy. Innovation, reliability, and ethics are the pillars upon which we build our partnership with the Indian healthcare community.
Medvok Medical
